97 related articles for article (PubMed ID: 19534379)
1. Myeloperoxidase index and subtypes of acute myeloid leukemia.
Eivazi-Ziaei J
J Pak Med Assoc; 2009 Jun; 59(6):406-7. PubMed ID: 19534379
[TBL] [Abstract][Full Text] [Related]
2. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients.
Bacher U; Kern W; Schnittger S; Hiddemann W; Schoch C; Haferlach T
Ann Hematol; 2005 Nov; 84(12):785-91. PubMed ID: 16132906
[TBL] [Abstract][Full Text] [Related]
3. Classification of acute myeloid leukaemia in trephine biopsies with special reference to lactoferrin.
Al Safadi L; Köhler G; Schaefer HE
Anticancer Res; 1998; 18(5B):3677-84. PubMed ID: 9854476
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase-deficient polymorphonuclear leucocytes. (IV): Relation to FAB-classification in acute myeloid leukaemia.
Bendix-Hansen K; Nielsen HK
Scand J Haematol; 1985 Aug; 35(2):174-7. PubMed ID: 2996122
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of CD7 expression in adult acute myeloid leukemia].
Saito T; Usui N; Dobashi N; Maki N; Asai O; Yano S; Kato A; Watanabe H; Katori M; Nagamine M; Ogihara A; Yamazaki H; Kobayashi T; Tajima N; Kuraishi Y
Rinsho Ketsueki; 1998 Jul; 39(7):481-6. PubMed ID: 9750454
[TBL] [Abstract][Full Text] [Related]
8. Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients.
Walter RB; Othus M; Burnett AK; Löwenberg B; Kantarjian HM; Ossenkoppele GJ; Hills RK; van Montfort KG; Ravandi F; Evans A; Pierce SR; Appelbaum FR; Estey EH
Blood; 2013 Mar; 121(13):2424-31. PubMed ID: 23325837
[TBL] [Abstract][Full Text] [Related]
9. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
[TBL] [Abstract][Full Text] [Related]
10. A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification.
Wong O; Harris F; Yiying W; Hua F
Regul Toxicol Pharmacol; 2009 Dec; 55(3):340-52. PubMed ID: 19703505
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia-FAB classification and its correlation with clinico-haematological features.
Hassan K; Qureshi M; Shafi S; Ikram N; Akhtar MJ
J Pak Med Assoc; 1993 Oct; 43(10):200-3. PubMed ID: 8114248
[TBL] [Abstract][Full Text] [Related]
13. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic significance of serum measurements of lactoferrin, lysozyme and myeloperoxidase in acute myeloid leukemia (AML): recognition of a new variant, high-lactoferrin AML.
Oberg G; Dahl R; Ellegaard J; Sundström C; Vaeth M; Venge P
Eur J Haematol; 1987 Feb; 38(2):148-55. PubMed ID: 3036571
[TBL] [Abstract][Full Text] [Related]
15. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
16. Analysis of hematogones in bone marrow from acute myeloid leukaemia cases posttherapy.
Zheng J; Du W; Yao J; You Y; Li W; He Y; Li X; Liu W; Wu Y; Hu Y; Jin R; Zou P; Huang S; Hu Y; Zhang M
Eur J Clin Invest; 2013 Nov; 43(11):1140-6. PubMed ID: 23992300
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia.
Guy J; Antony-Debré I; Benayoun E; Arnoux I; Fossat C; Le Garff-Tavernier M; Raimbault A; Imbert M; Maynadié M; Lacombe F; Béné MC; Wagner-Ballon O;
Br J Haematol; 2013 May; 161(4):551-5. PubMed ID: 23432206
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase gene expression in acute leukemias.
Morishita Y; Yano K
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1459-62. PubMed ID: 2560887
[TBL] [Abstract][Full Text] [Related]
19. Usefulness and limitations of serum and urine lysozyme levels in the classification of acute myeloid leukemia: an analysis of 208 cases.
Sexton C; Buss D; Powell B; O'Connor M; Rainer R; Woodruff R; Cruz J; Pettenati M; Rao PN; Case LD
Leuk Res; 1996 Jun; 20(6):467-72. PubMed ID: 8709618
[TBL] [Abstract][Full Text] [Related]
20. Frequency of French-American-British subtypes of acute myeloid leukaemia in a tertiary care hospital of Karachi.
Bhatti IA; Haider G; Khan YI; Saifuddin T
J Pak Med Assoc; 2022 Mar; 72(3):537-539. PubMed ID: 35320239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
